We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Sierra Bancorp
BSRR
$532M
| $813K | 0.01% |
48,444
-4,027
| -8% | -$72.1K |
|
|
HTB
702
HomeTrust Bancshares
HTB
$866M
| $813K | 0.01% |
59,868
-6,851
| -10% | -$98.7K |
|
|
VRS
703
DELISTED
Verso Corporation
VRS
| $805K | 0.01% |
102,050
-8,731
| -8% | -$106K |
|
704
Deckers Outdoor
DECK
$14.1B
| $804K | 0.01% |
21,924
-72,576
| -77% | -$2.51M |
|
|
PVLA
705
Palvella Therapeutics
PVLA
$2.05B
| $790K | 0.01% |
4,771
+1,050
| +28% | +$239K |
|
706
Regenxbio
RGNX
$616M
| $786K | 0.01% |
28,566
-5,261
| -16% | -$172K |
|
707
PTC
PTC
$15.3B
| $784K | 0.01% |
9,483
+4,919
| +108% | +$419K |
|
708
Live Nation Entertainment
LYV
$42.9B
| $782K | 0.01% |
14,507
-271,402
| -95% | -$14M |
|
709
Southern First Bancshares
SFST
$581M
| $771K | 0.01% |
31,941
+9,699
| +44% | +$246K |
|
|
AAWW
710
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $765K | 0.01% |
+12,557
| New | +$689K |
|
711
Lantheus
LNTH
$6.51B
| $762K | 0.01% |
60,117
-40,223
| -40% | -$552K |
|
|
HNGR
712
DELISTED
Hanger Inc.
HNGR
| $757K | 0.01% |
+47,859
| New | +$863K |
|
713
Heritage Financial
HFWA
$1.22B
| $752K | 0.01% |
40,872
-6,123
| -13% | -$120K |
|
714
HNI Corp
HNI
$3.08B
| $739K | 0.01% |
23,565
| – | – |
|
715
MarineMax
HZO
$748M
| $738K | 0.01% |
+28,758
| New | +$791K |
|
|
FSP
716
Franklin Street Properties
FSP
$49.9M
| $733K | 0.01% |
200,251
+107,978
| +117% | +$506K |
|
717
Chesapeake Utilities
CPK
$3.28B
| $732K | 0.01% |
8,688
-6,480
| -43% | -$535K |
|
718
Cyclerion Therapeutics
CYCN
$15.2M
| $730K | 0.01% |
6,003
-1,517
| -20% | -$173K |
|
|
TCRR
719
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $727K | 0.01% |
35,768
-6,105
| -15% | -$107K |
|
|
ADMS
720
DELISTED
Adamas Pharmaceuticals
ADMS
| $725K | 0.01% |
175,990
+49,287
| +39% | +$191K |
|
721
LSI Industries
LYTS
$834M
| $724K | 0.01% |
107,204
-1,120
| -1% | -$7.24K |
|
722
Cartesian Therapeutics
RNAC
$218M
| $724K | 0.01% |
9,737
+1,664
| +21% | +$127K |
|
|
CBIO
723
Crescent Biopharma
CBIO
$546M
| $707K | 0.01% |
2,303
-588
| -20% | -$225K |
|
|
CURO
724
DELISTED
CURO Group Holdings Corp.
CURO
| $701K | 0.01% |
99,473
+81,222
| +445% | +$618K |
|
|
BELFB
725
Bel Fuse Inc Class B
BELFB
$3.45B
| $698K | 0.01% |
65,358
-16,563
| -20% | -$188K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.